For semaglutide, this testing includes exposure to temperature cycles, light, and humidity
Patients who may not be appropriate candidates include: Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Those with a history of severe hypersensitivity reactions to semaglutide Patients with a history of pancreatitis (relative contraindication requiring careful risk-benefit assessment) Pregnant women or those planning pregnancy (contraindicated for weight management
However, effects on advanced fibrosis remain under investigation, with phase 2 trials of semaglutide showing MASH resolution without confirmed fibrosis improvement
Allergic reaction indicators Rarely, body aches accompanied by hives, facial swelling, difficulty breathing, or rapid heart rate may indicate an allergic reaction to tirzepatide
For more insights into GLP-1 medications and how they work, explore Zappy Healths GLP-1 guide.
A single judge oversees the pre-trial activities, such as discovery and preliminary hearings
